arrow
M

Maurizio Pieroni

azienda ospedaliero-universitaria careggi
H指数:45
被引数:7,937

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy

变异重分类对肥厚型心肌病患者基因检测产率和临床预后的影响

2026-08-010
PRE
Evolving Epidemiology of Cardiomyopathies at a National Referral Centre: a 30-Year Longitudinal Study

国家转诊中心心肌病的演变流行病学:一项为期30年的纵向研究

2026-05-190
PRE
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact

家族性遗传性甲状腺素转运蛋白淀粉样变性中的级联遗传筛查:诊断与预后影响

2026-04-070
OA
Photon-Counting Computed Tomography for Tissue Characterization in Patients With a Left Ventricular Hypertrophic Phenotype

光子计数计算机断层扫描在左心室肥厚表型患者组织表征中的应用

2026-04-010
PRE
Anti-Drug Antibodies in Patients with Fabry Disease Treated with Agalsidase-Alpha or -Beta: A Retrospective Italian Multicenter Study

法布里病患者使用阿加糖酶α或β治疗后的抗药抗体:一项意大利多中心回顾性研究

Cells
IF5.2
2026-01-010
OA
Prognostic role of myocardial storage, hypertrophy and inflammation/fibrosis in Fabry Cardiomyopathy: a new predictive score including T1 values
2025-12-150
PRE
Patterns of LV Remodeling and Outcomes in Fabry Disease

LV重塑的模式及Fabry病患者的预后

2025-11-280
OAAI
Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD)

心脏磁共振对法布里病患者临床管理的影响:来自意大利法布里病研究和临床网络(CIRCLE-FD)的数据

2025-11-050
PRE
Sex-specific prognostic thresholds of left ventricular hypertrophy in fabry disease

法布雷病中左心室肥厚的性别特异性预后阈值

2025-10-010
OAAI
Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy

基于智能手机的应用开发,以支持原发性左心室肥厚患者的鉴别诊断

2025-10-010
OAAI
Artificial intelligence applications in hypertrophic cardiomyopathy: turns and loopholes

人工智能在肥厚型心肌病中的应用:转折与漏洞

2025-08-010
PRE
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY)

托斯卡纳和翁布里亚地区疑似心脏淀粉样变患者的特征:来自心脏淀粉样变登记研究(CARRY)的见解

2025-07-310
PRE